WEREWOLF THERAPEUTICS, INC. (HOWL) Free cash flow 2020–2025
WEREWOLF THERAPEUTICS, INC. (HOWL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$60.3MFY2025 · since FY2020: -$19.2M → -$60.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.3M | -6.8% |
| FY2024 | -$56.4M | -69.1% |
| FY2023 | -$33.4M | +24.5% |
| FY2022 | -$44.2M | -1.9% |
| FY2021 | -$43.4M | -126.1% |
| FY2020 | -$19.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice